Arca
Skip to content
Tools
Tools

Bilisoft Phototherapy System

Unit, Neonatal Phototherapy. 510(k) K053568, from Lumitex, Inc. (Strongsville, OH). Product code LBI, class 2.

As of Nov 18, 2026, K053568 is an FDA 510(k) held by Lumitex, Inc., substantially equivalent on Apr 17, 2006 after 116 days, with no recalls tied to it in FDA's recall database.

  • Review time: 116 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Bili-Soft Phototherapy System provides light therapy for the treatment of hyperbilirubinemia, commonly know as neonatal jaundice, during the newborn period in the hospital or home setting. The Bili-Soft Phototherapy System emits a narrow band of blue light considered to be the most effective in the treatment of hyperbilirubinemia.

Cited as a predicate

3 later 510(k) summaries name this device as a predicate

Other LBI clearances

The newest 510(k)s for the same product code; their median review was 211 days; see every LBI device

Record

Type
Traditional
Received
Dec 22, 2005
Review panel
General Hospital
Regulation
21 CFR 880.5700

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.